In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls
Main Authors: | Helene Broch Tenstad, Pernille Just Vinholt, Christian Nielsen, Hanne Lindegaard, Søren Andreas Just |
---|---|
Format: | Article |
Language: | English |
Published: |
AVES
2021-10-01
|
Series: | European Journal of Rheumatology |
Online Access: | https://www.eurjrheumatol.org/en/in-vitro-effect-of-biological-and-conventional-disease-modifying-antirheumatic-drugs-on-fibrocyte-differentiation-in-patients-with-rheumatoid-arthritis-and-healthy-controls-133407 |
Similar Items
-
The in vitro effect of antirheumatic drugs on platelet function
by: Camilla Brødsgaard Nielsen, et al.
Published: (2020-02-01) -
Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
by: Emery, P, et al.
Published: (1994) -
DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis
by: Susan Siyu Wang, et al.
Published: (2023-07-01) -
Lung lesion caused by the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yuriy Vladimirovich Murav'ev, et al.
Published: (2010-12-01) -
Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?
by: O. B. Iaremenko, et al.
Published: (2023-07-01)